Global Drug Purchasing and Management Market Growth (Status and Outlook) 2025-2031

According to this study, the global Drug Purchasing and Management market size will reach US$ 20870 million by 2031.

Drug Purchasing and Management refers to the comprehensive processes involved in the selection, procurement, storage, distribution, and utilization of pharmaceutical products within a healthcare system, organization, or facility. It plays a critical role in ensuring that medicines are available, affordable, safe, effective, and used appropriately to meet the needs of the population or specific patient groups.

United States market for Drug Purchasing and Management is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Drug Purchasing and Management is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Drug Purchasing and Management is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Drug Purchasing and Management players cover McKesson, Almac, Cardinal Health, AmerisourceBergen, The PHOENIX Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Drug Purchasing and Management Industry Forecast” looks at past sales and reviews total world Drug Purchasing and Management sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Purchasing and Management sales for 2025 through 2031. With Drug Purchasing and Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Purchasing and Management industry.

This Insight Report provides a comprehensive analysis of the global Drug Purchasing and Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Purchasing and Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Purchasing and Management market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Purchasing and Management and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Purchasing and Management.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Purchasing and Management market by product type, application, key players and key regions and countries.

Segmentation by Type:
Comprehensive Pharmaceutical Distribution
Specialty Drug Management
Others

Segmentation by Application:
Medical Institutions
Retail Terminals
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
McKesson
Almac
Cardinal Health
AmerisourceBergen
The PHOENIX Group
Sinopharm Group Co.,Ltd.
Walgreens Boots Alliance
MEDIPAL HOLDINGS
Alfresa Holdings
Catalent
PCI Pharma Services
Samsung Biologics

Please note: The report will take approximately 2 business days to prepare and deliver. Show more